Author(s):
Sumit Kumar, Rajni Tanwar, Dinesh Kumar, Amandeep Mor4, Nicky, monu
Email(s):
dineshpotlia123@gmail.com
DOI:
10.52711/0974-360X.2025.00131 
Address:
Sumit Kumar1, Rajni Tanwar2, Dinesh Kumar3*, Amandeep Mor4, Nicky5, monu6
1Assistant Professor, Department of Pharmaceutical Sciences, Central University of Haryana, Jant-Pali, Mahendergarh, (Haryana), India - 123031,
2Associate Professor, School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh, Punjab, India.
3Associate Professor, School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh, Punjab, India.
4Research Scholar, Om sterling global University, Hisar Haryana.
5Assistant Professor, School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh, Punjab, India.
6Amity Institute of Pharmacy, Amity University, Haryana, Amity Education Valley Gurugram, Manesar, Panchgaon, Haryana, India.
*Corresponding Author
Published In:
Volume - 18,
Issue - 2,
Year - 2025
ABSTRACT:
Virosomes are nanoscale structures that combine viruses and liposomes, encapsulating therapeutic molecules or antigens. They have potential applications in drug delivery, vaccination, and gene therapy. Their unique ability to fuse with cellular membranes enhances therapeutic efficacy and reduces side effects. Virosomes can induce robust immune responses against diseases and cancers, and can be used in gene delivery, targeted drug delivery systems, and personalized medicine. Advancements in virosome engineering are being explored.
Cite this article:
Sumit Kumar, Rajni Tanwar, Dinesh Kumar, Amandeep Mor4, Nicky, monu. Virosomes: Recent Concepts and Multiple Application. Research Journal of Pharmacy and Technology.2025;18(2):893-7. doi: 10.52711/0974-360X.2025.00131
Cite(Electronic):
Sumit Kumar, Rajni Tanwar, Dinesh Kumar, Amandeep Mor4, Nicky, monu. Virosomes: Recent Concepts and Multiple Application. Research Journal of Pharmacy and Technology.2025;18(2):893-7. doi: 10.52711/0974-360X.2025.00131 Available on: https://rjptonline.org/AbstractView.aspx?PID=2025-18-2-63
REFERENCES:
1. Daemen T, de Mare A, Bungener L, de Jonge J, Huckriede A, Wilschut J. Virosomes for antigen and DNA delivery. Advanced Drug Delivery Reviews. 2005; Jan 10; 57(3): 451-63. https://doi.org/10.1016/j.addr.2004.09.005
2. Kaneda Y. Virosomes: evolution of the liposome as a targeted drug delivery system. Advanced Drug Delivery Reviews. 2000; Sep 30; 43(2-3): 197-205. https://doi.org/10.1016/S0169-409X(00)00069-7
3. Kalra N, Dhanya V, Saini V, Jeyabalan G. Virosomes: as a drug delivery carrier. American Journal of Advanced Drug Delivery. 2013; 1(1): 29-35.
4. Singh N, Gautam SP, Kumari N, Kaur R, Kaur M. Virosomes as novel drug delivery system: an overview. Pharma Tutor. 2017; Sep 1; 5(9): 47-55.
5. Shaikh SN, Raza S, Ansari MA, Khan GJ, Athar SH. Overview on virosomes as a novel carrier for drug delivery. Journal of Drug Delivery and Therapeutics. 2018; 8(6-s): 429-34. https://doi.org/10.22270/jddt.v8i6-s.2163
6. Metcalfe IC, Glück R. Virosomes for vaccine delivery. Immunopotentiators in Modern Vaccines. 2006; Jan 1: 179-89. https://doi.org/10.1016/B978-012088403-2/50012-5
7. Dhachinamoorthi D. Buccal Drug Delivery System–An Overview. Research Journal of Pharmacy and Technology. 2009; Dec 28; 2(4): 653-63.
8. Patidar V, Sharma D, Maliwal D, Chatap V. Penetration Enhancement Techniques for Transdermal Drug Delivery System. Research Journal of Pharmacy and Technology. 2009; 2(1): 28-33.
9. Rathor S, Soni P, Lal D. Unique drug delivery system: Virosomes. Research Journal of Pharmaceutical Dosage Forms and Technology. 2019; 11(4): 304-8.
10. Saraf S, Paliwal S, Kaur CD, Saraf S. Sphingosomes a novel approach to vesicular drug delivery. Research Journal of Pharmacy and Technology. 2011; 4(5): 661-6.
11. Bungener L, Huckriede A, Wilschut J, Daemen T. Virosomes as a vaccine delivery system. In14th European Immunology Meeting (EFIS 2000) 2000 (pp. 845-850). Medimond Publishing Co.
12. Nalawade R, Nalawade A, Patwa H, Ghode S, Raut R, Chatur VM. Virosomes: A Drug Carrier System. J Hosp Pharm. 2021; 16(1): 1-9.
13. Aher VD, Banerjee S, Mahaur KK. Vaccine: An ultimate way of immunization. Research Journal of Pharmacy and Technology. 2011; 4(3): 369-74.
14. Gaurav B, Manisha K, Vilasrao K. Virosome–drug and vaccine delivery system. World Journal of Pharmacy and Pharmaceutical Sciences. 2014; Aug 10; 3(10): 437-47.
15. Cusi MG. Applications of influenza virosomes as a delivery system. Human Vaccines. 2006; Jan 31; 2(1): 1-7. https://doi.org/10.4161/hv.2.1.2494
16. Hodgson CP, Solaiman F. Virosomes: cationic liposomes enhance retroviral transduction. Nature Biotechnology. 1996; Mar 1; 14(3): 339-42. https://doi.org/10.1038/nbt0396-339
17. Adamina M, Guller U, Bracci L, Heberer M, Spagnoli GC, Schumacher R. Clinical applications of virosomes in cancer immunotherapy. Expert Opinion on Biological Therapy. 2006; Nov 1; 6(11): 1113-21.https://doi.org/10.1517/14712598.6.11.1113
18. Sivakumar SM, Nirmala L, Swarnalakshmi R, Sivakumar L, Anilbabu B, Shanmugarajan TS, Anbu J, Ravichandran V, Sukumaran N. Preparation and in vitro evaluation of Hepatitis B vaccine encapsulated chitosan microparticles. Research Journal of Pharmacy and Technology. 2009; 2(1): 117-9.
19. Bron R, Ortiz A, Dijkstra J, Stegmann T, Wilschut J. [23] Preparation, properties, and applications of reconstituted influenza virus envelopes (virosomes). Methods in Enzymology. 1993; 220: 313-331. https://doi.org/10.1016/0076-6879(93)20091-G
20. Wilschut J. Influenza vaccines: the virosome concept. Immunology Letters. 2009; Feb 21; 122(2): 118-21. https://doi.org/10.1016/j.imlet.2008.11.006
21. Srikanth K, Nappinnai M, Gupta VR. Proniosomes: A novel drug carrier system. Research Journal of Pharmacy and Technology. 2010; 3(3): 709-11.
22. Jana U, Pal S, Mohanta GP, Manna PK, Manavalan R. Nanoparticles: A Potential Approach for Drug Delivery. Research Journal of Pharmacy and Technology. 2011; 4(7): 1016-9.
23. Derle DV, Kasliwal NH, Gandhi PP, Yeole DR. Development, Characterisation and Evaluation of Niosomes and Liposomes of Bacitracin Zinc. Research Journal of Pharmacy and Technology. 2010; 3(4): 1295-300.
24. Kalra A, Sharma S. Virosomes: a viral envelope system having a promising application in vaccination and drug delivery system. Nanopharmaceutical Advanced Delivery Systems. 2021; Jan 12: 145-60. https://doi.org/10.1002/9781119711698.ch7
25. Patel SS, Patel MJ, Patel NM. Need, Development and application of Virosomal system in medicine. International Journal of Pharmaceutical Sciences and Nanotechnology. 2010; Nov 30; 3(3): 1065-74. https://doi.org/10.37285/ijpsn.2010.3.3.4
26. Kotkar T, Dhavale S, Patel B, Hardikar SR, Mutha S, Bhosale AV. Chronopharmaceutical Drug Delivery System: A Review. Research Journal of Pharmacy and Technology. 2009; 2(1): 58-64.
27. Patil PR, Chaulang GM, Akolkotkar A, Mutha SS, Hardikar SR, Bhosale AV. Self-emulsifying drug delivery system: A review. Res J Pharm Technol. 2008; 1: 313-23.
28. Kaneda Y. Virosome: a novel vector to enable multi-modal strategies for cancer therapy. Advanced Drug Delivery Reviews. 2012; 64(8): 730-8. https://doi.org/10.1016/j.addr.2011.03.007
29. Amacker M, Moese S, Kammer AR, Helenius A, Zurbriggen R. Influenza virosomes as delivery systems for antigens. Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic Acids and Vaccines. 2009; Nov 20: 377-93. DOI:10.1002/9780470688397
30. Asadi K, Gholami A. Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review. International Journal of Biological Macromolecules. 2021; 182: 648-58. https://doi.org/10.1016/j.ijbiomac.2021.04.005